Although diabetics are at increased risk of structural heart disease from vascular complications, the concept of diabetic cardiomyopathy suggests a direct cellular insult to the myocardium. Several investigations, mainly echocardiographic population-based studies, documented a uniform association between diabetic cardiomyopathy and the presence of cardiac hypertrophy and myocardial stiffness. In the following review, we attempt to provide a comprehensive insight to discuss the possible underlying mechanisms, especially the role of PPARs in diabetic cardiomyopathy.
CITATION STYLE
Li, Y. X., Cheng, K. C., & Cheng, J. T. (2014). Role of PPAR-d in diabetic cardiomyopathy. In Diabetic Cardiomyopathy: Biochemical and Molecular Mechanisms (pp. 201–212). Springer New York. https://doi.org/10.1007/978-1-4614-9317-4_12
Mendeley helps you to discover research relevant for your work.